Michael Martin
Observer of the Board
Univercells
Austria
Biography
Michal Martin brings to our board over ten years of experience in biotech, venture capital, pharma business development and R&D. Prior to TVI, Michael was a member of Global Licensing & BD Takeda, Vice President of Preclinical Development of Intellikine, and held several executive positions with TargeGen (acquired by Sanofi-Aventis), Arena Pharmaceuticals, and the Monsanto Corporation Michal Martin brings to our board over ten years of experience in biotech, venture capital, pharma business development and R&D. Prior to TVI, Michael was a member of Global Licensing & BD Takeda, Vice President of Preclinical Development of Intellikine, and held several executive positions with TargeGen (acquired by Sanofi-Aventis), Arena Pharmaceuticals, and the Monsanto Corporation
Research Interest
pharma
